EP4490151A1 — Solid forms, salts, and processes of preparation of a cdk2 inhibitor
Assigned to Incyte Corp · Expires 2025-01-15 · 1y expired
What this patent protects
The present application provides solid forms and salts of a compound of Formula (I): (I) pharmaceutical compositions thereof, methods of treating a disease or disorder associated with CDK2 using the same, and processes of preparing the compound of Formula (I) and the solid forms …
USPTO Abstract
The present application provides solid forms and salts of a compound of Formula (I): (I) pharmaceutical compositions thereof, methods of treating a disease or disorder associated with CDK2 using the same, and processes of preparing the compound of Formula (I) and the solid forms and salts.
Drugs covered by this patent
- Verzenio (abemaciclib) · Eli Lilly
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.